'%2 years following irradiation) due to cardiac disease in three, progression of the malignancy in two and infection in one. In addition to constrictive pericarditis, extensive myocardial fibrosis and involvement of the antero-lateral papillary muscle and chordae tendineae of the mitral valve were demonstrated at postmortem examination. These factors may explain the progression of cardiac disease despite an initial symptomatic improvement following pericardiectomy.
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Physiopathology of heart disease INJURY TO VIRTUALLY ALL normal intrathoracic structures has been reported following radiation therapy for a variety of neoplastic conditions. Ionizing radiation has been reported to cause pathologic changes in the pleura, lungs, heart, coronary arteries and great vessels. Pericardial damage is the most commonly reported clinically significant effect on the heart.1 Radiation to the mediastinum may cause isolated electrocardiographic changes, acute pericarditis, pericardial effusion and, less commonly, constrictive pericarditis.' Clinically significant pericardial disease following irradiation is related primarily to the pericardial radiation dose, elapsed time over which the radiation has been administered, daily fraction size and volume of heart irradiated. There are numerous reports on radiation-induced constrictive pericarditis in adults2-19 but only a few cases have been recorded in childhood.6' 20 21 Because the incidence, course and prognosis of radiation-induced constrictive pericarditis in childhood is not known, we have reviewed the experience with this lesion at our institution. of the anthracyclines, daunorubicin and adriamycin, three years after completion of mediastinal irradiation. Other chemotherapeutic agents employed in the eight patients included chlorambucil, vincristine, prednisone and methotrexate.
Risk Factors. Table 2 shows the radiation technique employed, dose delivered to the mid-plane and the number of patients with Hodgkin's disease who subsequently developed constrictive pericarditis. There were no cases of constrictive pericarditis following the use of supravoltage technique whereas 15% of all patients treated by orthovoltage technique developed constrictive pericarditis (P < 0.05). Among patients in this latter group who received less than 4000 rad, two out of 35 (6%) developed constrictive pericarditis and in those who received more than 4000 rad, four out of seven (57%) (P < 0.001) developed constrictive pericarditis.
Diagnosis and Clinical Findings
Symptoms of constrictive pericarditis developed at an average of 15 months (4/12 -32%,2 years) after irradiation and were preceded in five patients by acute pericarditis and/or pericardial effusion, which developed from 11/2 months to one year after irradiation (table 1) . Dyspnea and decrease in exercise tolerance were invariably present. On physical examination, pulsus paradoxicus was present in six patients, neck vein distention in six, pericardial friction rub in three, gallop rhythms in four and muffled heart sounds in two. All eight patients had hepatomegaly. An apical regurgitant systolic murmur and mid-diastolic rumble were each noted in two patients. Protein losing enteropathy and atrial flutter were seen in one patient each (cases 5 and 7, respectively).
Laboratorv Studies
The standard electrocardiogram revealed characteristic low QRS voltages and ST-T wave changes in all eight patients. Sinus tachycardia was present in six patients and atrial flutter in one. During the course of the disease process, right or left atrial hypertrophy or both developed in six of eight; intraventricular conduction delay developed in six of cardiomegaly and fibrosis of the pericardium in each patient with additional myocardial cellular degeneration and fibrosis in all (figs. 2, 3). There was marked right ventricular enlargement and hypertrophy in three of the cases (patients 1, 4, and 5) and left ventricular hypertrophy in one (patient 7). Focal endocardial thickening of the left ventricular papillary muscles and chordae tendineae of the mitral valve were observed in patients 4, 5, and 7. In two of these, the mitral valve edges were rolled, thickened and nodular; the presence of jet lesions in the left atrium was strongly suggestive of mitral regurgitation (fig. 4 ).
Discussion
The development of constrictive pericarditis following mediastinal irradiation has been previously reported in adults2 19 aged 22 to 68 years and in four children' 20 aged 13 to 15 years. In our patients, the development of constrictive pericarditis was related both to pericardial radiation dose and to the technique utilized. The effect of total cardiac volume irradiated and the presence or absence of tumor invading the pericardium prior to irradiation has not been evaluated. All pertinent data indicate that pericarditis and constrictive pericarditis are dose related and that the radiation dose per fraction and the total elapsed time of irradiation are important factors.22 23 C(alculations of dosage reaching the anterior pericardium in orthovoltage vs supravoltage techniques revealed that the pericardial dose delivered is much greater with orthovoltage than with supravoltage when the mid-plane dose is equivalent ( fig. 1) . Although constrictive pericarditis did not develop in ouir patients who received 4000-4400 rad total midplane utilizing supravoltage, its occurrence has been reported. 4 6 However, when children were irradiated to the same mid-plane dose utilizing the orthovoltage equipment, a striking incidence of 57T (P < .001) was encountered. Thus, careful attention to technique should reduce the incidence of constrictive pericarditis.
Prospective studies on the prevalence of acute pericarditis have set the incidence of this complication at 7W04. 6 to 21% 24 of all patients with Hodgkin's disease who were treated with irradiation. The effect of radiation is, of course, not limited to the pericardium.
It has been demonstrated in patients1 and experimental animal studies25"26 that the myocardium is also damaged. Myocardial changes have been documented by both light and electron microscopy. These studies suggest that there is an initial acute Phlotograph of the heart (case 5) The expected finding of a small quiet heart in constrictive pericarditis has previously been pointed out to be a common misconception.32 Cardiomegaly was a prominent finding in our patients and is probably due to cardiac chamber enlargement and the frequent coexistence of effusion.
The influence of chemotherapy in the pathogenesis of constrictive pericarditis and the symptomatology in these patients deserves comment. Actinomycin D potentiates the action of radiation therapy33 and probably contributed additionally to the deleterious effects of irradiation in the mediastinal structures of the patient who received this antibiotic concurrently with irradiation. Further, the anthracyclines are cardiotoxic. [34] [35] [36] The maximum cumulative dose recommended should not exceed 600 mg/m2, particularly for adriamycin.34 Since irradiation may promote cardiac damage, these chemotherapeutic agents probably contributed to the abnormal cardiac findings in patient 7. Experience in the latter and in several other patients who developed cardiac abnormalities with the anthracyclines at this institution have led us to limit the maximum cumulative dose of these drugs to 300 mg/m2 in patients who receive mediastinal irradiation. We are unaware of a cardiotoxic relationship with the antitumor agents employed in the other patients.
With current supravoltage technique, pericardial complications are infrequent. Our study strongly suggests that with the use of supravoltage technique and carefully controlled radiation dosage, the frequency of constrictive pericarditis after mediastinal irradiation may be significantly reduced. Patients who have received mediastinal irradiation should be carefully monitored, probably for an indefinite period of time, for the possible iatrogenic cardiac complications of the therapy. In those who develop constrictive pericarditis, complete decortication of the constrictive pericardium is indicated. Significant improvement in cardiac symptomatology may be anticipated but the prognosis remains guarded.
